Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban after anticoagulation-associated intracerebral hemorrhage in atrial fibrillation
2014-000112-33Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of apixaban in Atrial fibrillation (AFib) (2 arms), sponsored by University Medical Center Utrecht. Started Jul 2014; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2014-000112-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000112-33.